Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2025-02-19 History
Report ID 236880
Drug Identification Number 02402068
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) TAZOBACTAM PIPERACILLIN
Strength(s) 0.25G 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes ml
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2024-09-05
Estimated end date Unknown
Actual end date 2025-02-18
Shortage status Resolved
Updated date 2025-02-19
Company comments PIPERACILLIN AND TAZOBACTAM FOR INJECTION will be avaible under Eugia label : 02528673
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-02-19 French Compare
v4 2025-02-19 English Compare
v3 2024-09-06 English Compare
v2 2024-09-05 French Compare
v1 2024-09-05 English Compare

Showing 1 to 5 of 5